Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,513,586
+$1,827,979 QoQ
Shares Held
227,063
+153.4% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Jun 30, 2026CallValue
$3,497,013
CallShares
315,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. REPL ranks #61 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in REPL
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,497,013 | 315,900 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $2,513,586 | 227,063 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $685,607 | 89,622 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,874,250 | 245,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $2,840,037 | 292,185 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,910,061 | 455,862 | Shares | Sole | 2026-03-31 | |
| 2025-09-30 | $155,030 | 37,000 | Call | Sole | 2026-03-31 | |
| 2025-06-30 | $3,456,900 | 372,110 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $705,111 | 75,900 | Call | Sole | 2026-02-27 | |
| 2025-03-31 | $1,509,260 | 154,796 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $2,026,353 | 167,329 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,737,061 | 158,491 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $537,300 | 59,700 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $886,689 | 108,530 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $2,448,948 | 290,504 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $2,026,029 | 118,412 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,624,115 | 113,011 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,616,401 | 91,529 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,309,516 | 48,144 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $857,852 | 49,673 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $31,918 | 1,826 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $89,161 | 5,251 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,185,624 | 43,750 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,391,745 | 46,955 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,350,956 | 61,191 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,556,737 | 83,800 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $329,348 | 8,633 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $219,841 | 9,550 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $272,131 | 10,951 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $140,756 | 14,118 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||